HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O2 levels

Journal of Cell Science

Volumn 116, Issue 15, 2003, Pages 3041-3049

  Masson, Norma ^a   Ratcliffe, Peter J ^a  

^a Henry Wellcome Bldg of Genomic Med ^*  (United Kingdom)

Author keywords

Asparaginyl hydroxylation; Hypoxia inducible factor ; Prolyl hydroxylation; Ubiquitylation; Von Hippel Lindau protein

Indexed keywords

2 OXOGLUTARIC ACID; AMINO ACID; ASPARAGINE DERIVATIVE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; OXYGENASE; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE;

BIOAVAILABILITY; CELL ACTIVITY; CELL LEVEL; CELL METABOLISM; CELLULAR DISTRIBUTION; CHEMOSENSITIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; HYDROXYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ALTERNATIVE SPLICING; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL HYPOXIA; HUMANS; HYDROXYLATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; OXYGEN; PROCOLLAGEN-PROLINE DIOXYGENASE; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0041885339     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.00655     Document Type: Review

References (97)

1. Bae, M.-Y., Ahn, M.-Y., Jeong, J.-W., Bae, M.-H., Lee, Y. M., Bae, S.-Y., Park, J.-W., Kim, K.-R. and Kim, K.-W. (2002). Jab1 interacts directly with HIF-1α and regulates its stability. J. Biol. Chem. 277, 9-12.
2. Beroud, C., Joly, D., Gallou, C., Staroz, F., Orfanelli, M. T. and Junien, C. (1998). Software and database for the analysis of mutations in the VHL gene. Nucleic Acids Res 26, 256-258.
3. Berra, E., Richard, D. E., Gothie, E. and Pouyssegur, J. (2001). HIF-1-dependent transcriptional activity is required for oxygen-mediated HIF-1α degradation. FEBS Lett. 491, 85-90.
4. Bhattacharya, S., Michels, C. L., Leung, M.-K., Arany, Z. P., Kung, A. L. and Livingston, D. M. (1999). Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev. 13, 64-75.
5. Brahimi-Horn, C., Berra, E. and Pouyssegur, J. (2001). Hypoxia, the tumour's gateway to progression along the angiogenic pathway. Trends Cell Biol. 11, S32-S36.
6. Bruick, R. K. and McKnight, S. L. (2001). A conserved family of prolyl-4-Hydroxylases that modify HIF. Science 294, 1337-1340.
7. Bunn, H. F. and Poyton, R. O. (1996). Oxygen sensing and molecular adaptation to hypoxia. Physiological Rev. 76, 839-885.
8. Chan, D. A., Sutphin, P. D., Denko, N. C. and Giaccia, A. J. (2002). Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1α. J. Biol. Chem. 277, 40112-40117.
9. Cioffi, C. L., Qin Liu, X., Kosinski, P. A., Garay, M. and Bowen, B. R. (2003) Differential regulation of HIF-1α prolyl-4-hydroxylase genes by hypoxia in human cardiovascular cells. Biochem. Biophys. Res. Commun. 303, 947-953.
10. Cockman, M. E., Masson, N., Mole, D. R., Jaakkola, P., Chang, G. W., Clifford, S. C., Maher, E. R., Pugh, C. W., Ratcliffe, P. J. and Maxwell, P. H. (2000). Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 275, 25733-25741.
11. Conrad, P. W., Freeman, T. L., Beitner-Johnson, D. and Millhorn, D. E. (1999). EPAS1 trans-activation during hypoxia requires p42/p44 MAPK. J. Biol. Chem. 274, 33709-33713.
12. Dames, S. A., Martinez-Yamout, M., Guzman, R. N. D., Dyson, H. J. and Wright, P. E. (2002). Structural basis for hif-1α/CBP recognition in the cellular hypoxic response. Proc. Natl. Acad. Sci. USA 99, 5271-5276.
13. Dann, C. E. I., Bruick, R. K. and Deisenhofer, J. (2002). Structure of factor-inhibiting hypoxia-inducible factor 1: an asparaginyl hydroxylase involved in the hypoxic response pathway. Proc. Natl. Acad. Sci. USA 99, 15351-15356.
14. Ebert, B. L. and Bunn, H. F. (1999). Regulation of the Erythropoietin Gene. Blood 94, 1864-1877.
15. Elkins, J. M., Hewitson, K. S., McNeill, L. A., Seibel, J. F., Schlemminger, I., Pugh, C. W., Ratcliffe, P. J. and Schofield, C. J. (2003). Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIE-1α. J. Biol. Chem. 278, 1802-1806.
16. Elson, D. A., Thurston, G., Huang, L. E., Ginzinger, D. G., McDonald, D. M., Johnson, R. S. and Arbeit, J. M. (2001). Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1α. Genes Dev. 15, 2520-2532.
17. Ema, M., Hirota, K., Mimura, J., Abe, H., Yodoi, J., Sogawa, K., Poellinger, L. and Fujii-Kuriyama, Y. (1999). Molecular mechanisms of transcription activation by HLF and HIF1 alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J. 18, 1905-1914.
18. Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A. et al. (2001). C. elegans EGL-9 and mammalian homologues define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54.
19. Erez, N., Milyavsky, M., Goldfinger, N., Peles, E., Gudkov, A. V. and Rotter, V. (2002). Falkor, a novel cell growth regulator isolated by a functional genetic screen. Oncogene 21, 6713-6721.
20. Freedman, S. J., Sun, Z.-Y. J., Poy, F., Kung, A. L., Livingston, D. M., Wagner, G. and Eck, M. J. (2002). Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α. Proc. Natl. Acad. Sci. USA 99, 5367-5372.
21. Gnarra, J. R., Zhou, S., Merrill, M. J., Wagner, J. R., Krumm, A., Papavassiliou, E., Oldfield, E. H., Klausner, R. D. and Linehan, W. M. (1996). Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc. Natl. Acad. Sci. USA 93, 10589-10594.
22. Gorlach, A., Camenisch, G., Kvietikova, I., Vogt, L., Wenger, R. H. and Gassmann, M. (2000). Efficient translation of mouse hypoxia-inducible factor-1alpha under normoxic and hypoxic conditions. Biochim. Biophys. Acta 1493, 125-134.
23. Gradin, K., Takasaki, C., Fujii-Kuriyama, Y. and Sogawa, K. (2002). The transcriptional activation function of the HIF-like factor requires phosphorylation at a conserved threonine. J. Biol. Chem. 277, 23508-23514.
24. Groulx, I. and Lee, S. (2002). Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein. Mol. Cell. Biol. 22, 5319-5336.
25. Gu, Y.-Z., Hogenesch, J. B. and Bradfield, C. A. (2000). The PAS superfamily: sensors of environmental and developmental signals. Annu. Rev. Pharm. Toxicol. 40, 519-561.
26. Hewitson, K. S., McNeill, L. A., Riordan, M. V., Tian, Y.-M., Bullock, A. N., Welford, R. W., Elkins, J. M., Oldham, N. J., Bhattacharya, S., Gleadle, J. M. et al. (2002). Hypoxia inducible factor (HIF) asparagine hydroxylase is identical to Factor Inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 277, 26351-26355.
27. Hofer, T., Desbaillets, I., Hopfl, G., Gassmann, M. and Wenger, R. H. (2001). Dissecting hypoxia-dependent and hypoxia-independent steps in the HIF-1α activation cascade: implications for HIF-1α gene therapy. FASEB J. 15, 2715-2717.
28. Hon, W. C., Wilson, M. I., Harlos, K., Claridge, T. D., Schofield, C. J., Pugh, C. W., Maxwell, P. H., Ratcliffe, P. J., Stuart, D. I. and Jones, E. Y. (2002). Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL. Nature 417, 975-978.
29. Huang, L. E., Arany, Z., Livingston, D. M. and Bunn, H. F. (1996). Activation of hypoxia-inducible transcription factor depends primarily on redox-sensitive stabilization of its α subunit. J. Biol. Chem. 271, 32253-32259.
30. Huang, L. E., Gu, J., Schau, M. and Bunn, H. F. (1998). Regulation of hypoxia-inducible factor 1α is mediated by an oxygen-dependent domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 95, 7987-7992.
31. Huang, J., Zhao, Q., Mooney, S. M. and Lee, F. S. (2002). Sequence determinants in hypoxia inducible factor-1a for hydroxylation by the prolyl hydroxylases PHD1, PHD2 and PHD3. J. Biol. Chem. 277, 39792-39800.
32. Iliopoulos, O., Levy, A. P., Jiang, C., Kaelin, W. G., Jr and Goldberg, M. A. (1996). Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Natl. Acad. Sci. USA 93, 10595-10599.
33. 2 sensing. Science 292, 464-468.
34. Ivan, M., Haberberger, T., Gervasi, D. C., Michelson, K. S., Gunzler, V., Kondo, K., Yang, H., Sorokina, I., Conaway, R. C., Conaway, J. W. et al. (2002). Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc. Natl. Acad. Sci. USA 99, 13459-13464.
35. 2-regulated prolyl hydroxylation. Science 292, 468-472.
36. Jeong, J.-W., Bae, M.-K., Ahn, M.-Y., Kim, S.-H., Sohn, T.-K., Bae, M.-H., Yoo, M.-A., Song, E. J., Lee, K.-J. and Kim, K.-W. (2002). Regulation and destabilization of HIF-1α by ARD1-mediated acetylation. Cell 111, 709-720.
37. Jewell, U. R., Kvietikova, I., Scheid, A., Bauer, C., Wenger, R. H. and Gassmann, M. (2001). Induction of HIF-1alpha in response to hypoxia is instantaneous. FASEB J. 15, 1312-1314.
38. 2 tension. Am. J. Physiol. 271, C1172-C1180.
39. Jiang, B.-H., Zheng, J. Z., Leung, S. W., Roe, R. and Semenza, G. L. (1997). Transactivation and inhibitory domains of hypoxia-inducible factor 1α. Modulation of transcriptional activity by oxygen tension. J. Biol. Chem. 272, 19253-19260.
40. Kaelin, W. G. (2002). Molecular Basis of the VHL Hereditary Cancer Syndrome. Nature Rev. Cancer 2, 673-682.
41. Kallio, P. J., Okamoto, K., O'Brien, S., Carrero, P., Makino, Y., Tanaka, H. and Poellinger, L. (1998). Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1α. EMBO J. 17, 6573-6586.
42. Kallio, P. J., Wilson, W. J., O'Brien, S., Makino, Y. and Poellinger, L. (1999). Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway. J. Biol. Chem. 274, 6519-6525.
43. c-Src leads to elevated hypoxia-inducible factor (HIF)-1α expression under normoxia. J. Biol. Chem. 277, 42919-42925.
44. Kim, M. S., Kwon, H. J., Lee, Y. M., Baek, J. H., Jang, J.-E., Lee, S.-W., Moon, E.-J., Kim, H.-S., Lee, S.-K., Chung, H. Y. et al. (2001). Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat. Med. 7, 437-443.
45. Kivirikko, K. I. and Myllyharju, J. (1998). Prolyl 4-hydroxylases and their protein disulfide isomerase subunit. Matrix Biol. 16, 357-368.
46. Knowles, H. J., Raval, R. R., Harris, A. L. and Ratcliffe, P. J. (2003). Effect of ascorbate on the activity of hypoxia inducible factor (HIF) in cancer cells. Cancer Res. 270, 1900-1915.
47. Kondo, K., Kico, J., Nakamura, E., Lechpammer, M. and Kaelin, W. G. J. (2002). Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell 1, 237-246.
48. Kuznetsova, A. V., Meller, J., Schnell, P. O., Nash, J. A., Ignacak, M. L., Sanchez, Y., Conaway, J. W., Conaway, R. C. and Czyzyk-Krzeska, M. F. (2003). von Hippel-Lindau protein binds hyperphosphorylated large subunit of RNA polymerase II through a proline hydroxylation motif and targets it for ubiquitination. Proc. Natl. Acad. Sci. USA 100, 2706-2711.
49. Lando, D., Peet, D. J., Gorman, J. J., Whelan, D. A., Whitelaw, M. L. and Bruick, R. K. (2002a). FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16, 1466-1471.
50. Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J. and Whitelaw, M. L. (2002b). Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch. Science 295, 858-861.
51. Laughner, E., Taghavi, P., Chiles, K., Mahon, P. C. and Semenza, G. L. (2001). HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol. 21, 3995-4004.
52. Lavista-Llanos, S., Centanin, L., Irisarri, M., Russo, D. M., Gleadle, J. M., Bocca, S. N., Muzzopappa, M., Ratcliffe, P. J. and Wappner, P. (2002). Control of the hypoxic reponse in Drosophila melanogaster by the basic helix-loop-helix PAS protein Similar. Mol. Cell. Biol. 22, 6842-6853.
53. Lieb, M. E., Menzies, K., Moschella, M. C., Ni, R. and Taubman, M. B. (2002). Mammalian EGLN genes have distinct patterns of mRNA expression and regulation. Biochem. Cell Biol. 80, 421-426.
54. Lipscomb, E. A., Sarmiere, P. D. and Freeman, R. S. (2001). SM-20 is a novel mitochondrial protein that causes caspase-dependent cell death in nerve growth factor-dependent neurons. J. Biol. Chem. 276, 5085-5092.
55. Luo, J. C. and Shibuya, M. (2001). A variant of nuclear localization signal of bipartite-type is required for the nuclear translocation of hypoxia inducible factors (1α, 2α and 3α). Oncogene 20, 1435-1444.
56. Madden, S. L., Galella, E. A., Riley, D., Bertelsen, A. H. and Beaudry, G. A. (1996). Induction of cell growth regulatory genes by p53. Cancer Res. 56, 5384-5390.
57. Mahon, P. C., Hirota, K. and Semenza, G. L. (2001). FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 15, 2675-2686.
58. Makino, Y., Cao, R., Svensson, K., Bertilsson, G., Asman, M., Tanaka, H., Cao, Y., Berkenstam, A. and Poellinger, L. (2001). Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 414, 550-554.
59. Makino, Y., Kanopka, A., Wilson, W. J., Tanaka, H. and Poellinger, L. (2002). IPAS is an hypoxia-inducible splicing variant of the HIF-3a locus. J. Biol. Chem. 277, 32405-32408.
60. Maranchie, J. K., Vasselli, J. R., Riss, J., Bonifacino, J. S., Linehan, W. M. and Klausner, R. D. (2002). The contribution of VHL substrate binding and HIF1-α to the phenotype of VHL loss in renal cell carcinoma. Cancer Cell 1, 247-255.
61. Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W. and Ratcliffe, P. J. (2001). Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation. EMBO J. 20, 5197-5206.
62. Maxwell, P. H., Pugh, C. W. and Ratcliffe, P. J. (1993). Inducible operation of the erythropoietin 3′ enhancer in multiple cell lines: evidence for a widespread oxygen sensing mechanism. Proc. Natl. Acad. Sci. USA 90, 2423-2427.
63. Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R. and Ratcliffe, P. J. (1999). The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271-275.
64. Maxwell, P. H., Pugh, C. W. and Ratcliffe, P. J. (2001). Activation of the HIF pathway in cancer. Curr. Opin. Genet. Dev. 11, 293-299.
65. Maynard, M. A., Qi, H., Chung, J., Lee, E. H. L., Kondo, Y., Hara, S., Conaway, R. C., Conaway, J. W. and Ohh, M. (2003). Multiple splice variants of the human HIF-3α locus are targets of the VHL E3 ubiquitin ligase complex. J. Biol. Chem. 278, 11032-11040.
66. McNeill, L. A., Hewitson, K. S., Claridge, T. D., Seibel, J. F., Horsfall, L. E. and Schofield, C. J. (2002). Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the β-carbon of asparagine-803. J. Biochem. 367, 571-575.
67. Metzen, E., Berchner-Pfannschmidt, U., Stengel, P., Marxsen, J. H., Stolze, I., Klinger, M., Huang, W. Q., Wotzlaw, C., Hellwig-Burgel, T., Jelkmann, W., Acker, H. and Fandrey, J. (2003). Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing. J. Cell Sci. 116, 1319-1326.
68. Min, J.-H., Yang, H., Ivan, M., Gertler, F., Kaelin, W. G. J. and Pavletich, N. P. (2002). Structure of an HIF-1α-pVHL complex: hydroxyproline recognition in signaling. Science 296, 1886-1889.
69. O'Rourke, J. F., Tian, Y.-M., Ratcliffe, P. J. and Pugh, C. W. (1999). Oxygen-regulated and transactivating domains in endothelial PAS protein 1: comparison with hypoxia inducible factor-1α. J. Biol. Chem. 274, 2060-2071.
70. Oehme, F., Ellinghaus, P., Kolkhof, P., Smith, T. J., Ramakrishnan, S., Hutter, J., Schramm, M. and Flamme, I. (2002). Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors. Biochem. Biophys. Res. Commun. 296, 343-349.
71. Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T. Y., Huang, L. E., Pavletich, N., Chau, V. and Kaelin, W. G. (2000). Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat. Cell. Biol. 2, 423-427.
72. Prescott, A. G. and Lloyd, M. D. (2000). The iron(II) and 2-oxoacid-dependent dioxygenases and their role in metabolism. Natural Product Reports 17, 367-383.
73. Pugh, C. W., O'Rourke, J. F., Nagao, M., Gleadle, J. M. and Ratcliffe, P. J. (1997). Activation of hypoxia inducible factor-1; definition of regulatory domains within the α subunit. J. Biol. Chem. 272, 11205-11214.
74. Richard, D. E., Berra, E., Gothie, E., Roux, D. and Pouysségur, J. (1999). p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1α (HIF-1α) and enhance the transcriptional activity of HIF-1. J. Biol. Chem. 274, 32631-32637.
75. Sang, N., Fang, J., Srinivas, V., Leshchinsky, I. and Caro, J. (2002). Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP. Mol. Cell. Biol. 22, 2984-2992.
76. Schofield, C. J. and Zhang, Z. (1999). Structural and mechanistic studies on 2-oxoglutarate-dependent oxygenases and related enzymes. Curr. Opin. Struct. Biol. 9, 722-731.
77. Semenza, G. L. (1999). Perspectives on oxygen sensing. Cell 98, 281-284.
78. Semenza, G. L. (2000a). HIF-1 and human disease: one highly involved factor. Genes Dev. 14, 1983-1991.
79. Semenza, G. L. (2000b). HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol. 88, 1474-1480.
80. Semenza, G. L. and Wang, G. L. (1992). A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12, 5447-5454.
81. Seth, P., Krop, I., Porter, D. and Polyak, K. (2002). Novel estrogen and tamoxifen induced genes identified by SAGE (serial analysis of gene expression). Oncogene 21, 836-843.
82. Sutter, C. H., Laughner, E. and Semenza, G. L. (2000). Hypoxia-inducible factor 1a protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. Proc. Natl. Acad. Sci. USA 97, 4748-4753.
83. Taylor, M. S. (2001). Characterization and comparative analysis of the EGLN gene family. Gene 275, 125-132.
84. Treins, C., Giorgetti-Peraldi, S., Murdaca, J., Semenza, G. L. and Van Obberghen, E. (2002). Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J. Biol. Chem. 277, 27975-27981.
85. Valegard, K., van Scheltinga, A. C. T., Lloyd, M. D., Hara, T., Ramaswamy, S., Perrakis, A., Thompson, A., Lee, H. J., Baldwin, J. E., Schofield, C. J. et al. (1998). Structure of a cephalosporin synthase. Nature 394, 805-809.
86. Vincent, K. A., Shyu, K. G., Luo, Y., Magner, M., Tio, R. A., Jiang, C., Goldberg, M. A., Akita, G. Y., Gregory, R. J. and Isner, J. M. (2000). Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor. Circulation 102, 2255-2261.
87. Wang, G. L. and Semenza, G. L. (1993). Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82, 3610-3615.
88. 2 tension. Proc. Natl. Acad. Sci. USA 92, 5510-5514.
89. Wax, S. D., Rosenfield, C. L. and Taubman, M. B. (1994). Identification of a novel growth factor-responsive gene in vascular smooth muscle cells. J. Biol. Chem. 269, 13041-13047.
90. Wenger, R. H. (2000). Mammalian oxygen sensing, signalling and gene regulation. J. Exp. Biol. 20, 1253-1263.
91. 2-regulated gene expression. FASEB J. 16, 1151-1162.
92. William, C., Masson, N., Tian, Y. M., Mahmood, S. A., Wilson, M. I., Bicknell, R., Eckardt, K. U., Maxwell, P. H., Ratcliffe, P. J. and Pugh, C. W. (2002). Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis. Proc. Natl. Acad. Sci. USA 99, 10423-10428.
93. Yu, F., White, S. B., Zhao, Q. and Lee, F. S. (2001). HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl. Acad. Sci. USA 98, 9630-9635.
94. Yuan, Y., Hilliard, G., Ferguson, T. and Millhorn, D. E. (2003). Cobalt inhibits the interaction between hypoxia inducible factor-α and von Hippel-Lindau protein by direct binding to hypoxia inducible factor-α. J. Biol. Chem. 278, 15911-15916.
95. Zhang, Z. H., Ren, J. S., Stammers, D. K., Baldwin, J. E., Harlos, K. and Schofield, C. J. (2000). Structural origins of the selectivity of the trifunctional oxygenase clavaminic acid synthase. Nat. Struct. Biol. 7, 127-133.
96. Zhou, J., Gunsior, M., Bachmann, B. O., Townsend, C. A. and Solomon, E. I. (1998). Substrate binding to the alpha-ketoglutarate-dependent non-heme iron enzyme clavaminate synthase 2: coupling mechanism of oxidative decarboxylation and hydroxylation. J. Am. Chem. Soc. 120, 13539-13540.
97. Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., Chen, E., Gottschalk, A. R., Ryan, H. E., Johnson, R. S., Jefferson, A. B. et al. (2000). Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev. 14, 391-396.